CoreLab Partners' new logo and brand identity launched

CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.

"We are pleased to launch our new logo and brand identity combined with a new comprehensive web site (http://www.corelabpartners.com) to the biopharmaceutical drug development sector," said CoreLab Partners' President and Chief Executive Officer, Mike Woehler. "As we continue our integration of the RadPharm and Medifacts functional teams, CoreLabs is creating a global business model which provides an innovative suite of imaging sciences solutions combined with a full spectrum of cardiac safety services; a powerful business proposition as our sponsors seek to streamline their vendor partners and establish long-term strategic relationships going forward," added Woehler.

Science. Service. Technology.

The CoreLab Partners' positioning includes the introduction of a new web site, distinct logo, new company tag line and refined mission statement designed to establish both a strong visual association with the company and effectively communicate a unique value proposition to the biopharmaceutical industry. CoreLab Partners' new brand identity is being launched to coincide with the Partnerships in Clinical Trials Conference in Orlando, Florida. Key company executives will be on hand at stands #515, 539 to meet with the sponsor community to answer any questions and discuss their expanded suite of service solutions.

SOURCE CoreLab Partners, Inc

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI models redefine TIL scoring in breast cancer but face challenges in real-world validation